BAY-876
BAY-876, a chemical probe, is an orally active and selective glucose transporter 1 (GLUT1) inhibitor with an IC50 of 2 nM. BAY-876 is >130-fold more selective for GLUT1 than GLUT2, GLUT3, and GLUT4. BAY-876 is also a potent blocker of glycolytic metabolism and ovarian cancer growth. In addition, BAY-876 can induce the formation of disulfide bonds in actin cytoskeletal proteins, leading to the occurrence of cellular disulfidptosis[1][2][3].
Product Specifications
CAS Number
1799753-84-6
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Disulfidptosis; GLUT
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/BAY-876.html
Purity
99.67
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C(C1=NC2=CC(F)=CC=C2C(C(NC3=C(C)N(CC4=CC=C(C#N)C=C4)N=C3C(F)(F)F)=O)=C1)N
Molecular Formula
C24H16F4N6O2
Molecular Weight
496.42
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
GLUT1; GLUT2; GLUT3; GLUT4
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
N-(2,6-Dichlorophenyl)-4,5-dihydro-1-nitroso-1H-imidazol-2-amine
DOG-1 / TMEM16A (Gastrointestinal Stromal Tumor Marker) (DG1/1486), CF640R conjugate, 0.1mg/mL
Cytokeratin 18 (KRT18) (rKRT18/1190), CF647 conjugate, 0.1mg/mL
